Clinical trial
Prospective Analysis of Restorelle in the Treatment of Uterine Prolapse
NCT02921451 is registered in ClinicalTrials.gov with Michigan Institution of Women's Health PC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Analysis of Restorelle in the Treatment of Uterine Prolapse
- Lead sponsor
- Michigan Institution of Women's Health PC
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- August 31, 2016
- Completion date
- August 31, 2020
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.